Sales and Marketing

Showing 15 posts of 11528 posts found.

Sanofi and Regeneron posts positive Praluent cholesterol data

June 12, 2017 Research and Development, Sales and Marketing Regeneron, Sanofi, praluent

Sanofi and Regeneron were able to update its PCSK9 therapy Praluent with the positive data showing it could reduce levels …
abbvieuse_036_low

AbbVie loses $15 million Depakote birth-defect case

June 12, 2017 Sales and Marketing AbbVie, Abbott, Depakote

Court cases for the anti-seizure medicine Depakote continue to rumble on for AbbVie, with the latest case finding AbbVie liable …
top_ten_1

Top Ten most read pages on Pharmafile.com this week

June 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

Lilly bolsters diabetes assets with $55m KeyBioscience deal

June 9, 2017 Medical Communications, Sales and Marketing Eli Lilly, KeyBiosciences

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …
artificial-intelligence-2228610_960_720

Data-driven insights: Keeping pace with the technological boom

June 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, data, technology

If you want to understand the importance of data, look at Google and Facebook – neither company is out of …
pfizer_sky

Pfizer gets fast-track approval for rare heart condition

June 8, 2017 Sales and Marketing Pfizer

Pfizer’s tafamidis has already been given approval in 40 countries across the globe but it has not currently broken into …
gavel-1017953_1280

Servier fights fine over antitrust breaches

June 7, 2017 Manufacturing and Production, Research and Development, Sales and Marketing European Commission, Servier, generic

Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust …

Novel Drug Movers and Shakers 2013-2016

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

To view the original whitepaper from NDA, please click here.Small and Medium Sized Companies in North America Lead Novel Drug …

Recipharm opens new GMP suite for clinical trial material

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) …
europe-1395916_640

New game, new rules: Pathways for better and affordable medicines in Europe

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …

BMS’ Opdivo scores eighth approval in Europe for bladder cancer

June 5, 2017 Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, Europe, European Commission, bladder cancer, immunotherapy

Bristol-Myers Squibb has announced that its flagship immunotherapy treatment Opdivo (nivolumab) has secured its eighth approval in Europe as the …

Merck KGaA signs potential $1 billion deal with UK biotech

June 5, 2017 Sales and Marketing F-star, Merck KGaA

UK biotech, F-Star, has scored a boost to its coffers with another link-up with a big pharma company, this time …
aging_-_hand

Latest prostate cancer research could provide boost for J&J

June 5, 2017 Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer

Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …
shutterstock_187433765

New targeted therapy promises strong response rate across 17 cancer types

June 5, 2017 Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology

Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …
The Gateway to Local Adoption Series

Latest content